| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |